SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460610
Filing Date
2012-11-08
Accepted
2012-11-08 16:42:20
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d399084d10q.htm 10-Q 569107
2 EX-31.1 d399084dex311.htm EX-31.1 8811
3 EX-31.2 d399084dex312.htm EX-31.2 8829
4 EX-32.1 d399084dex321.htm EX-32.1 5075
  Complete submission text file 0001193125-12-460610.txt   4072415

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnt-20120930.xml EX-101.INS 597560
6 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20120930.xsd EX-101.SCH 33215
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20120930_cal.xml EX-101.CAL 52136
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20120930_def.xml EX-101.DEF 119147
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20120930_lab.xml EX-101.LAB 276378
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20120930_pre.xml EX-101.PRE 212364
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 121190583
SIC: 2834 Pharmaceutical Preparations